Frontiers in OncologyGenetic & Genomic MedicinePeer-reviewed journal article
5hmC-profiles in Puerto Rican Hispanic/Latino men with aggressive prostate cancer
Manishkumar S. PateliD, Mousa Almubarak, Jaime L. MattaiD, Carmen OrtíziD, Jarline Encarnación-MedinaiD, Gilberto Ruiz-Deyá, Julie DutiliD, Jasreman DhilloniD, Kosj YamoahiD, Anders BerglundiD, Hyun Park, Deepak KilariiD, Yoganand BalagurunathaniD, Liang WangiD, Jong Y. ParkiD
Abstract
Puerto Rican (PR) Hispanic/Latino (H/L) men are an understudied population that has the highest prostate cancer (PCa) specific mortality among other Hispanic populations. Little information is known about the higher mortality in PR H/L men. It is thought that epigenetic changes in key genes may play a critical role in aggressive tumors. We aimed to identify key 5-hydroxymethylcytosine (5hmC) changes in PR H/L men with aggressive PCa. We performed sequencing analysis using the 5hmC-enriched DNA from 22 prostate tumors and 24 adjacent normal FFPE samples. We identified 808 differentially methylated genes (DMGs) in tumors compared to adjacent normal tissues (FDR|0.4|). Pathway analysis of DMGs demonstrated that DNA repair pathway was most upregulated in tumors. Since 5hmC abundance positively correlates with gene expression levels, we further investigated 808 DMGs in TCGA PCa gene expression data. Further, we identified 59 DMGs (80.1%, FDR|1|) with significant gene expression changes in the same direction. Additionally, we identified 111 aggressiveness-related DMGs, of which, two hypomethylated genes (CCDC122, NUDT15) and four hypermethylated genes (PVT1, RPL30, TRMT12, UBR5) were found to be altered at transcriptomic level in a concordant manner in PR H/L PCa patients (N=86). The aberrant 5hmC (N=55) and GE (N=497) changes in these six genes were also associated with progression-free survival in the mixed PCa population. In conclusion, our study identified 59 DMGs showing concordant epigenetic and transcriptomic changes in tumor tissues and 111 DMGs showing association with aggressive PCa among PR H/L men.
- organism: human
- assay: DNA methylation
- research focus: differential expression
- approach: statistical model
- Citations
- 2
- FWCI
- 0.60
- Field percentile
- top 42%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- UHRF1, NSUN2, and NEIL1 were Detected as Clinical Biomarker Candidates in Prostate Adenocarcinoma with Potential Roles in Disease Pathogenesis
Buse Nur Kahyaoğulları, Turan Demircan·bioRxiv·Oct 23, 2021
- Methylation reprogramming associated with aggressive prostate cancer and ancestral disparities
Jenna Craddock, Pavlo Lutsik, … Vanessa M. Hayes·Molecular Systems BiologyPeer-reviewed·Oct 7, 2025
- Epigenetic analysis identifies factors driving racial disparity in prostate cancer
R. Rai, S. S. Yadav, … K. K. Yadav·bioRxiv·Jun 20, 2018
- 5-hydroxymethylcytosine sequencing in plasma cell-free DNA identifies unique epigenomic features in prostate cancer patients resistant to androgen deprivation therapy
Qianxia Li, Chiang‐Ching Huang, … Liang Wang·medRxiv·Oct 13, 2023
- The Landscape of Prostate Tumour Methylation
Jaron Arbet, Takafumi N. Yamaguchi, … Paul Christopher Boutros·Cancer DiscoveryPeer-reviewed·Jun 17, 2026
- Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA